Simultaneous Lymph Node and Vascular Suppression Using Ferumoxytol-Enhanced Magnetic Resonance Neurography

BACKGROUND AND PURPOSE: Lymph nodes and blood vessels are hyperintense on heavily T2-weighted magnetic resonance neurography (MRN) sequences, potentially confounding nerve visualization. This study prospectively determined a target time between intravenous (IV) administration of ferumoxytol, an ultrasmall superparamagnetic iron oxide nanoparticle, and MR acquisition for simultaneous lymph node (LN) and vascular signal suppression. MATERIALS AND METHODS: Cohort 1 (n=2, age=26.0, 30.6 years, 2 females) received IV ferumoxytol (255 mg) and underwent 5 separate neck MRN exams over a 50-hour time window to determine the target imaging time for LN signal suppression. Subsequently, cohort 2 (n=10, age=26.7 ± 2.7 years, 5 males/5 females) underwent post-ferumoxytol infusion brachial plexus MRN immediately (<1-hour) and at the target time determined from cohort 1 testing. Acquired sequences included 3D, T2-weighted STIR-FSE and double-echo steady state (DESS) at 3T. Two raters selected regions of interest (LN, nerve, artery, vein) to analyze mean contrast ratios (CRs). Two-sided Wilcoxon signed-rank tests with Bonferroni correction compared mean LN-to-muscle to nerve-to-muscle CRs (p<0.05 deemed statistically significant). Comparisons were also performed of mean artery-to-muscle and vein-to-muscle CRs against a nominal value of 0.2. Linear mixed effects (LME) models assessed effects of time, rater, subject, weight and anatomical location on mean CRs. RESULTS: Significantly lower mean LN-to-muscle than nerve-to-muscle CRs were observed at the target 15-hour time using STIR-FSE (CR=1.25-1.44 vs. 2.03-2.30) and DESS (CR=0.56-0.57 vs. 1.70-1.99). Mean artery-to-muscle and vein-to-muscle CRs were significantly less than 0.2 on STIR-FSE (CR=0.06-0.13). LME models confirmed decreased mean LN-to-muscle CR on STIR-FSE (by -1.41) and DESS (by -0.87) at 15-hours. CONCLUSIONS: Simultaneous LN and vascular signal suppression was achieved 15 hours post-ferumoxytol infusion on MRN sequences. Concurrent LN and vascular signal suppression may warrant further investigation into the ability to visualize small, difficult-to-assess nerves within the neck and axilla.

Authors

Institutions

Publication Details

Journal
American Journal of Neuroradiology
Published
2026-11-18
DOI
https://doi.org/10.3174/ajnr.a9720
Primary Topic
Advanced MRI Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Simultaneous Lymph Node and Vascular Suppression Using Ferumoxytol-Enhanced Magnetic Resonance Neurography

Darryl B. Sneag, Shayna Turbin, Ek T. Tan, Allison Sydney Lowe et al.
3 links
American Journal of Neuroradiology
Advanced MRI Techniques and Applications
article

Simultaneous Lymph Node and Vascular Suppression Using Ferumoxytol-Enhanced Magnetic Resonance Neurography

Darryl B. Sneag, Shayna Turbin, Ek T. Tan, Allison Sydney Lowe, MyLinh Duong
article en

Abstract

BACKGROUND AND PURPOSE: Lymph nodes and blood vessels are hyperintense on heavily T2-weighted magnetic resonance neurography (MRN) sequences, potentially confounding nerve visualization. This study prospectively determined a target time between intravenous (IV) administration of ferumoxytol, an ultrasmall superparamagnetic iron oxide nanoparticle, and MR acquisition for simultaneous lymph node (LN) and vascular signal suppression. MATERIALS AND METHODS: Cohort 1 (n=2, age=26.0, 30.6 years, 2 females) received IV ferumoxytol (255 mg) and underwent 5 separate neck MRN exams over a 50-hour time window to determine the target imaging time for LN signal suppression. Subsequently, cohort 2 (n=10, age=26.7 ± 2.7 years, 5 males/5 females) underwent post-ferumoxytol infusion brachial plexus MRN immediately (<1-hour) and at the target time determined from cohort 1 testing. Acquired sequences included 3D, T2-weighted STIR-FSE and double-echo steady state (DESS) at 3T. Two raters selected regions of interest (LN, nerve, artery, vein) to analyze mean contrast ratios (CRs). Two-sided Wilcoxon signed-rank tests with Bonferroni correction compared mean LN-to-muscle to nerve-to-muscle CRs (p<0.05 deemed statistically significant). Comparisons were also performed of mean artery-to-muscle and vein-to-muscle CRs against a nominal value of 0.2. Linear mixed effects (LME) models assessed effects of time, rater, subject, weight and anatomical location on mean CRs. RESULTS: Significantly lower mean LN-to-muscle than nerve-to-muscle CRs were observed at the target 15-hour time using STIR-FSE (CR=1.25-1.44 vs. 2.03-2.30) and DESS (CR=0.56-0.57 vs. 1.70-1.99). Mean artery-to-muscle and vein-to-muscle CRs were significantly less than 0.2 on STIR-FSE (CR=0.06-0.13). LME models confirmed decreased mean LN-to-muscle CR on STIR-FSE (by -1.41) and DESS (by -0.87) at 15-hours. CONCLUSIONS: Simultaneous LN and vascular signal suppression was achieved 15 hours post-ferumoxytol infusion on MRN sequences. Concurrent LN and vascular signal suppression may warrant further investigation into the ability to visualize small, difficult-to-assess nerves within the neck and axilla.

American Journal of Neuroradiology
Hospital for Special Surgery (US)
Good health and well-being
Advanced MRI Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon